Diabetes type II: A risk factor for depression-Parkinson-Alzheimer?

Neurotoxicity Research

Volumn 19, Issue 2, 2011, Pages 253-265

  Riederer, Peter ^a   Bartl, Jasmin ^a   Laux, Gerd ^b   Grünblatt, Edna ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Inn Salzach Clinic   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amyloid; Alzheimer's disease; Cortisol; Depression; Diabetes; Insulin resistance; Parkinson's disease

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; CALBINDIN; CORTICOSTEROID RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; GLITAZONE DERIVATIVE; GLUCOCORTICOID RECEPTOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PIOGLITAZONE; ROSIGLITAZONE; TAU PROTEIN; TROGLITAZONE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC STRESS; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR DEPRESSION; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR;

ALZHEIMER DISEASE; ANIMALS; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; PARKINSON DISEASE; PITUITARY-ADRENAL SYSTEM; RISK FACTORS;

EID: 79751533413     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9203-1     Document Type: Article

References (175)

1. A Alexander 2008 Diabetes and depression-is there a link to the HPA axis? Occup Med (Lond) 58 308 author reply 308 (Pubitemid 351818486)
2. H Anisman 2009 Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder J Psychiatry Neurosci 34 4 20 19125209
3. DM Arduino AR Esteves SM Cardoso CR Oliveira 2009 Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease Neurochem Int 55 341 348 1:CAS:528:DC%2BD1MXotFClu7c%3D 19375464
4. E Area-Gomez AJ de Groof I Boldogh, et al. 2009 Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria Am J Pathol 175 1810 1816 1:CAS:528:DC%2BC3cXhslSjt78%3D 19834068
5. Z Arvanitakis RS Wilson JA Schneider JL Bienias DA Evans DA Bennett 2004 Diabetes mellitus and progression of rigidity and gait disturbance in older persons Neurology 63 996 1001 1:STN:280:DC%2BD2cvotlymug%3D%3D 15452289 (Pubitemid 39287906)
6. Z Arvanitakis RS Wilson JL Bienias DA Bennett 2007 Diabetes and parkinsonian signs in older persons Alzheimer Dis Assoc Disord 21 144 149 17545740 (Pubitemid 46878976)
7. N Awad M Gagnon C Messier 2004 The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function J Clin Exp Neuropsychol 26 1044 1080 15590460 (Pubitemid 39577337)
8. S Babri HG Badie S Khamenei MO Seyedlar 2007 Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats Brain Cogn 64 86 91 17349729 (Pubitemid 46783185)
9. C Bancher H Braak P Fischer KA Jellinger 1993 Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients Neurosci Lett 162 179 182 1:STN:280:DyaK2c7mslSgsA%3D%3D 8121624 (Pubitemid 23347976)
10. C Becker GP Brobert S Johansson SS Jick CR Meier 2008 Diabetes in patients with idiopathic Parkinson's disease Diabetes Care 31 1808 1812 18559656
11. D Berg 2008 Biomarkers for the early detection of Parkinson's and Alzheimer's disease Neurodegener Dis 5 133 136 18322370 (Pubitemid 351347830)
12. D Blum-Degen L Frölich S Hoyer P Riederer 1995 Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm Suppl 46 139 147 1:CAS:528:DyaK28XitVKht7g%3D 8821049 (Pubitemid 26043229)
13. I Bodis-Wollner 2003 Neuropsychological and perceptual defects in Parkinson's disease Parkinsonism Relat Disord 9 Suppl 2 S83 S89 12915072
14. H Braak E Braak D Yilmazer C Schultz RA de Vos EN Jansen 1995 Nigral and extranigral pathology in Parkinson's disease J Neural Transm Suppl 46 15 31 1:STN:280:DyaK28vhvVamtg%3D%3D 8821039 (Pubitemid 26043220)
15. AM Brands GJ Biessels LJ Kappelle, et al. 2007 Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study Dement Geriatr Cogn Disord 23 343 350 17374953 (Pubitemid 46631942)
16. Brands AM, Kessels RP, Ryan CM (2009) Cognition in adults with type 1 diabetes. In: Biessels GJ, Luchsinger JA (eds) Diabetes and the brain. Humana Press, New York, NY, pp 277-293
17. T Breidert J Callebert MT Heneka G Landreth JM Launay EC Hirsch 2002 Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease J Neurochem 82 615 624 1:CAS:528:DC%2BD38Xmt1ejsLY%3D 12153485 (Pubitemid 34831499)
18. J Brodbeck ME Balestra AM Saunders AD Roses RW Mahley Y Huang 2008 Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons Proc Natl Acad Sci USA 105 1343 1346 1:CAS:528:DC%2BD1cXhs1Kltrs%3D 18212130 (Pubitemid 351397055)
19. R Brookmeyer S Gray C Kawas 1998 Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am J Public Health 88 1337 1342 1:STN:280:DyaK1cvgvVSrsg%3D%3D 9736873 (Pubitemid 28402270)
20. BH Brummett SH Boyle IC Siegler, et al. 2008 Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR) Behav Genet 38 34 43 17955359 (Pubitemid 351164912)
21. A Carnemolla E Fossale E Agostoni, et al. 2009 Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease J Biol Chem 284 18167 18173 1:CAS:528:DC%2BD1MXnslegt7Y%3D 19433866
22. A Charlett RJ Dobbs AG Purkiss, et al. 1998 Cortisol is higher in parkinsonism and associated with gait deficit Acta Neurol Scand 97 77 85 1:STN:280:DyaK1c7nslSgtw%3D%3D 9517856 (Pubitemid 28085034)
23. RK Chaturvedi MF Beal 2008 PPAR: a therapeutic target in Parkinson's disease J Neurochem 106 506 518 1:CAS:528:DC%2BD1cXovFWgt78%3D 18384649
24. S Checkley 1996 The neuroendocrinology of depression and chronic stress Br Med Bull 52 597 617 1:CAS:528:DyaK28XmsFCgsbc%3D 8949260 (Pubitemid 26329157)
25. E Chevet PH Cameron MF Pelletier DY Thomas JJ Bergeron 2001 The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation Curr Opin Struct Biol 11 120 124 1:CAS:528: DC%2BD3MXhs1Kis7s%3D 11179901 (Pubitemid 32155561)
26. DM Clarke KC Currie 2009 Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence Med J Aust 190 S54 S60 19351294
27. T Coll R Rodriguez-Calvo E Barroso, et al. 2009 Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome Curr Mol Pharmacol 2 46 55 1:CAS:528:DC%2BD1MXkvVSgtrY%3D 20021445
28. MP Cosgrove LA Sargeant SJ Griffin 2008 Does depression increase the risk of developing type 2 diabetes? Occup Med (Lond) 58 7 14
29. S Craft 2005 Insulin resistance and cognitive impairment: a view through the prism of epidemiology Arch Neurol 62 1043 1044 16009754 (Pubitemid 41043722)
30. S Craft J Newcomer S Kanne, et al. 1996 Memory improvement following induced hyperinsulinemia in Alzheimer's disease Neurobiol Aging 17 123 130 1:STN:280:DyaK283ks1OltQ%3D%3D 8786794 (Pubitemid 26019103)
31. S Craft S Asthana JW Newcomer, et al. 1999 Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose Arch Gen Psychiatry 56 1135 1140 1:CAS:528:DC%2BD3cXls1Ortg%3D%3D 10591291
32. S Craft S Asthana DG Cook, et al. 2003 Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype Psychoneuroendocrinology 28 809 822 1:CAS:528:DC%2BD3sXks1altbs%3D 12812866 (Pubitemid 36695035)
33. M D'Amelio P Ragonese G Callari, et al. 2009 Diabetes preceding Parkinson's disease onset. A case-control study Parkinsonism Relat Disord 15 660 664 19356970
34. SM de la Monte M Tong 2009 Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease J Alzheimers Dis 17 4 817 825 19542621
35. SM de la Monte JR Wands 2008 Alzheimer's disease is type 3 diabetes-evidence reviewed J Diabetes Sci Technol 2 1101 1113 19885299
36. T Dehmer MT Heneka M Sastre J Dichgans JB Schulz 2004 Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation J Neurochem 88 494 501 1:CAS:528:DC%2BD2cXntlWjug%3D%3D 14690537 (Pubitemid 38084565)
37. MS Dhamoon JM Noble S Craft 2009 Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 72 292 293 19153380 author reply 293-294
38. TG Dinan 2005 Stress: the shared common component in major mental illnesses Eur Psychiatry 20 Suppl 3 S326 S328 16459244
39. PG Djupesland 2008 Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 71 864 18779519 author reply 864
40. JA Driver A Smith JE Buring JM Gaziano T Kurth G Logroscino 2008 Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease Diabetes Care 31 2003 2005 18599528
41. ML Duennwald S Lindquist 2008 Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity Genes Dev 22 3308 3319 1:CAS:528:DC%2BD1cXhsFaiu7nN 19015277
42. S El Messari C Leloup M Quignon MJ Brisorgueil L Penicaud M Arluison 1998 Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system J Comp Neurol 399 492 512 1:CAS:528:DyaK1cXlvVequ7Y%3D 9741479 (Pubitemid 28411112)
43. PK Elias MF Elias RB D'Agostino, et al. 1997 NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study Diabetes Care 20 1388 1395 1:STN:280:DyaK2svivFCgtw%3D%3D 9283785 (Pubitemid 27366813)
44. MF Elias PK Elias LM Sullivan PA Wolf RB D'Agostino 2003 Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study Int J Obes Relat Metab Disord 27 260 268 1:STN:280:DC%2BD3s%2FnsFOhtA%3D%3D 12587008 (Pubitemid 36255810)
45. JK Elmquist JN Marcus 2003 Rethinking the central causes of diabetes Nat Med 9 645 647 1:CAS:528:DC%2BD3sXktFOntbw%3D 12778157 (Pubitemid 36749208)
46. L Frölich D Blum-Degen HG Bernstein, et al. 1998 Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease J Neural Transm 105 423 438 9720972 (Pubitemid 28365027)
47. L Frölich D Blum-Degen P Riederer S Hoyer 1999 A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease Ann NY Acad Sci 893 290 293 10672251 (Pubitemid 30038089)
48. H Fukuyama M Ogawa H Yamauchi, et al. 1994 Altered cerebral energy metabolism in Alzheimer's disease: a PET study J Nucl Med 35 1 6 1:STN:280:DyaK2c%2Fps1Whtw%3D%3D 8271029 (Pubitemid 24018423)
49. OP Ganda AA Rossini AA Like 1976 Studies on streptozotocin diabetes Diabetes 25 595 603 1:CAS:528:DyaE28XkvFWlsLs%3D 132382
50. L Gasparini GK Gouras R Wang, et al. 2001 Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling J Neurosci 21 2561 2570 1:CAS:528:DC%2BD3MXjtVWkurs%3D 11306609 (Pubitemid 32298198)
51. Gerlach M, Reichmann H, Riederer P (eds) (2007) Die Parkinson-Krankheit, 4th edn. Springer, Wien-New York, Wien
52. SH Golden 2007 A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus Curr Diabetes Rev 3 252 259 18220683 (Pubitemid 350111108)
53. J Grosskreutz L Van Den Bosch BU Keller 2010 Calcium dysregulation in amyotrophic lateral sclerosis Cell Calcium 47 2 165 174 1:CAS:528: DC%2BC3cXjtVSms70%3D 20116097
54. E Grünblatt 2008 Commonalities in the genetics of Alzheimer's disease and Parkinson's disease Expert Rev Neurother 8 1865 1877 19086884
55. E Grünblatt S Hoyer P Riederer 2004 Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease J Neural Transm 111 367 386 14991460 (Pubitemid 38316611)
56. E Grünblatt E Koutsilieri S Hoyer P Riederer 2006 Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat J Alzheimers Dis 9 261 271 16914836 (Pubitemid 44253344)
57. E Grünblatt M Salkovic-Petrisic J Osmanovic P Riederer S Hoyer 2007 Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein J Neurochem 101 757 770 17448147 (Pubitemid 46633313)
58. E Grünblatt S Zehetmayer J Bartl, et al. 2009 Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study J Psychiatr Res 43 3 298 308 18603262
59. C Haense K Herholz WJ Jagust WD Heiss 2009 Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI) Dement Geriatr Cogn Disord 28 259 266 1:STN:280: DC%2BD1Mjht1Wnsg%3D%3D 19786778
60. LB Hassing MD Grant SM Hofer, et al. 2004 Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study J Int Neuropsychol Soc 10 599 607 15327738 (Pubitemid 39077200)
61. LB Hassing SM Hofer SE Nilsson, et al. 2004 Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study Age Ageing 33 355 361 15136287 (Pubitemid 39077242)
62. LB Hassing AK Dahl V Thorvaldsson, et al. 2009 Overweight in midlife and risk of dementia: a 40-year follow-up study Int J Obes (Lond) 33 893 898 1:STN:280:DC%2BD1Mrkt12rsw%3D%3D
63. K Herholz 2003 PET studies in dementia Ann Nucl Med 17 79 89 12790355 (Pubitemid 36693059)
64. EC Hirsch S Hunot 2009 Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8 382 397 1:CAS:528:DC%2BD1MXks1Sis70%3D 19296921
65. S Hoyer 1997 Models of Alzheimer's disease: cellular and molecular aspects J Neural Transm Suppl 49 11 21 1:STN:280:DyaK2svhtFCgsA%3D%3D 9266410 (Pubitemid 27351469)
66. S Hoyer 1998 Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis J Neural Transm 105 415 422 1:STN:280:DyaK1czosF2htw%3D%3D 9720971 (Pubitemid 28365026)
67. S Hoyer 2004 Glucose metabolism and insulin receptor signal transduction in Alzheimer disease Eur J Pharmacol 490 115 125 1:CAS:528:DC%2BD2cXjt1Shsbs%3D 15094078 (Pubitemid 38482165)
68. S Hoyer H Lannert 1999 Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats Ann NY Acad Sci 893 301 303 1:CAS:528: DC%2BD3cXms1GlsQ%3D%3D 10672254 (Pubitemid 30038092)
69. S Hoyer D Muller K Plaschke 1994 Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism J Neural Transm Suppl 44 259 268 1:CAS:528:DyaK2MXksVOrtb8%3D 7897397 (Pubitemid 24372903)
70. S Hoyer H Lannert M Noldner SS Chatterjee 1999 Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761) J Neural Transm 106 1171 1188 1:STN:280:DC%2BD3c7hsVGgtg%3D%3D 10651112 (Pubitemid 30009214)
71. S Hoyer SK Lee T Loffler R Schliebs 2000 Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann NY Acad Sci 920 256 258 1:CAS:528:DC%2BD3MXotlaitQ%3D%3D 11193160 (Pubitemid 32056578)
72. G Hu P Jousilahti S Bidel R Antikainen J Tuomilehto 2007 Type 2 diabetes and the risk of Parkinson's disease Diabetes Care 30 842 847 17251276 (Pubitemid 46562366)
73. HJ Huang KC Liang YY Chang HC Ke JY Lin HM Hsieh-Li 2009 The interaction between acute oligomer Abeta(1-40) and stress severely impaired spatial learning and memory Neurobiol Learn Mem 93 8 18 19660564
74. RL Hunter N Dragicevic K Seifert, et al. 2007 Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system J Neurochem 100 1375 1386 1:CAS:528:DC%2BD2sXjt1Grs7w%3D 17254027
75. K Ikesugi ML Mulhern CJ Madson, et al. 2006 Induction of endoplasmic reticulum stress in retinal pericytes by glucose deprivation Curr Eye Res 31 947 953 1:CAS:528:DC%2BD2sXhtFOnug%3D%3D 17114120
76. F Irie AL Fitzpatrick OL Lopez, et al. 2008 Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study Arch Neurol 65 89 93 18195144
77. Y Izumi KA Yamada M Matsukawa CF Zorumski 2003 Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats Diabetologia 46 1007 1012 1:CAS:528:DC%2BD3sXls1yns7w%3D 12827244 (Pubitemid 36961326)
78. RP Jaya Prasanthi E Schommer S Thomasson A Thompson G Feist O Ghribi 2008 Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease Mech Ageing Dev 129 649 655 1:STN:280:DC%2BD1cjovV2isg%3D%3D 18845178
79. K Jellinger H Braak E Braak P Fischer 1991 Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases Ann NY Acad Sci 640 203 209 1:STN:280:DyaK387jtlyrug%3D%3D 1776740
80. R Killick G Scales K Leroy, et al. 2009 Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice Biochem Biophys Res Commun 386 257 262 1:CAS:528:DC%2BD1MXnvVansr4%3D 19523444
81. AD Korczyn I Halperin 2009 Depression and dementia J Neurol Sci 283 139 142 19345960
82. P Kumar RK Kaundal S More SS Sharma 2009 Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease Behav Brain Res 197 398 403 1:CAS:528:DC%2BD1MXntV2lsg%3D%3D 18983875
83. J Kuusisto K Koivisto L Mykkanen, et al. 1997 Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study BMJ 315 1045 1049 1:CAS:528:DyaK2sXnt1Klsbg%3D 9366728 (Pubitemid 27458392)
84. I Kyrou C Tsigos 2009 Stress hormones: physiological stress and regulation of metabolism Curr Opin Pharmacol 9 787 793 1:CAS:528: DC%2BD1MXhsVGqs7vF 19758844
85. J Labad JF Price MW Strachan, et al. 2010 Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study Diabetologia. 53 467 471 1:CAS:528:DC%2BC3cXhsVygsbk%3D 20012009
86. G Landreth Q Jiang S Mandrekar M Heneka 2008 PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease Neurotherapeutics 5 481 489 1:CAS:528:DC%2BD1cXhtVOgtLrL 18625459 (Pubitemid 351952487)
87. H Lannert S Hoyer 1998 Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats Behav Neurosci 112 1199 1208 1:CAS:528:DyaK1cXnsleis7g%3D 9829797 (Pubitemid 28519002)
88. LJ Launer 2005 Diabetes and brain aging: epidemiologic evidence Curr Diab Rep 5 59 63 15663919 (Pubitemid 40277802)
89. DR Laybutt AM Preston MC Akerfeldt, et al. 2007 Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes Diabetologia 50 752 763 1:CAS:528:DC%2BD2sXitlOntL0%3D 17268797 (Pubitemid 46355827)
90. CL Leibson WA Rocca VA Hanson, et al. 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study Am J Epidemiol 145 301 308 1:STN:280:DyaK2s7ovVKkuw%3D%3D 9054233 (Pubitemid 27082028)
91. BE Leonard A Myint 2009 The psychoneuroimmunology of depression Hum Psychopharmacol 24 165 175 1:CAS:528:DC%2BD1MXlsVarsr8%3D 19212943
92. EH Lin CM Rutter W Katon, et al. 2010 Depression and advanced complications of diabetes: a prospective cohort study Diabetes Care 33 264 269 19933989
93. D Lindholm H Wootz L Korhonen 2006 ER stress and neurodegenerative diseases Cell Death Differ 13 385 392 1:CAS:528:DC%2BD28Xhtl2mt7o%3D 16397584
94. A Lobo LJ Launer L Fratiglioni, et al. 2000 Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 54 S4 S9 1:STN:280:DC%2BD3czht12juw%3D%3D 10854354
95. CM Long-Smith AM Sullivan YM Nolan 2009 The influence of microglia on the pathogenesis of Parkinson's disease Prog Neurobiol 89 277 287 1:CAS:528:DC%2BD1MXhtlCmsLzL 19686799
96. Luchsinger JA (2009) Type 2 diabetes, related conditions, and dementia. In: Biessels GJ, Luchsinger JA (eds) Diabetes and the brain. Humana Press, New York, NY, pp 323-342
97. JA Luchsinger DR Gustafson 2009 Adiposity, type 2 diabetes, and Alzheimer's disease J Alzheimers Dis 16 693 704 19387106
98. JA Luchsinger MX Tang S Shea R Mayeux 2004 Hyperinsulinemia and risk of Alzheimer disease Neurology 63 1187 1192 15477536 (Pubitemid 39350015)
99. AM Magarinos BS McEwen 2000 Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress Proc Natl Acad Sci USA 97 11056 11061 1:CAS:528: DC%2BD3cXnt1ahtrk%3D 11005876
100. RS McIntyre NL Rasgon DE Kemp, et al. 2009 Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap Curr Diab Rep 9 51 59 19192425
101. V Medved N Jovanovic VP Knapic 2009 The comorbidity of diabetes mellitus and psychiatric disorders Psychiatr Danub 21 585 588 19935498
102. C Messier K Teutenberg 2005 The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease Neural Plast 12 311 328 1:CAS:528:DC%2BD28Xps1WktA%3D%3D 16444902 (Pubitemid 43072007)
103. DB Miller JP O'Callaghan 2008 Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases? Metabolism 57 Suppl 2 S44 S49 1:CAS:528:DC%2BD1cXhtFektbnN 18803966
104. M Moosavi N Naghdi N Maghsoudi S Zahedi Asl 2006 The effect of intrahippocampal insulin microinjection on spatial learning and memory Horm Behav 50 748 752 1:CAS:528:DC%2BD28Xht1aju7bK 16890939 (Pubitemid 44738856)
105. LB Moran MB Graeber 2008 Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation Neurogenetics 9 1 13 18196299
106. PI Moreira MS Santos AM Moreno T Proenca R Seica CR Oliveira 2004 Effect of streptozotocin-induced diabetes on rat brain mitochondria J Neuroendocrinol 16 32 38 1:CAS:528:DC%2BD2cXhtVCit74%3D 14962073 (Pubitemid 38159390)
107. I Moroo T Yamada H Makino, et al. 1994 Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease Acta Neuropathol (Berl) 87 343 348 1:STN:280:DyaK2c3oslOkuw%3D%3D (Pubitemid 24091615)
108. L Mosconi B Nacmias S Sorbi, et al. 2004 Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease J Neurol Neurosurg Psychiatry 75 370 376 1:STN:280:DC%2BD2c7isVSmtg%3D%3D 14966149 (Pubitemid 38338764)
109. L Mosconi K Herholz I Prohovnik, et al. 2005 Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve J Neurol Neurosurg Psychiatry 76 15 23 1:STN:280: DC%2BD2cnjt1Glsg%3D%3D 15607989 (Pubitemid 40013485)
110. S Moussavi S Chatterji E Verdes A Tandon V Patel B Ustun 2007 Depression, chronic diseases, and decrements in health: results from the World Health Surveys Lancet 370 851 858 17826170 (Pubitemid 47362344)
111. T Muller S Muhlack 2008 Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease J Neural Transm 115 851 855 18335161
112. T Muller J Welnic S Muhlack 2007 Acute levodopa administration reduces cortisol release in patients with Parkinson's disease J Neural Transm. 114 347 350 1:STN:280:DC%2BD2s7htlCntg%3D%3D 16932991 (Pubitemid 46328653)
113. SP Nielsen OH Petersen 1972 Transport of calcium in the perfused submandibular gland of the cat J Physiol 223 685 697 1:STN:280: DyaE383jvVGnsw%3D%3D 5045737
114. T Oshitari N Hata S Yamamoto 2008 Endoplasmic reticulum stress and diabetic retinopathy Vasc Health Risk Manag 4 115 122 1:CAS:528: DC%2BD1cXkslKqu7c%3D 18629365 (Pubitemid 351460852)
115. J Osmanovic K Plaschke M Salkovic-Petrisic E Grünblatt P Riederer S Hoyer 2009 Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats Stress 13 2 123 131
116. A Ott RP Stolk A Hofman F van Harskamp DE Grobbee MM Breteler 1996 Association of diabetes mellitus and dementia: the Rotterdam Study Diabetologia 39 1392 1397 1:STN:280:DyaK2s%2Fos12rsw%3D%3D 8933010 (Pubitemid 26356072)
117. A Ott RP Stolk F van Harskamp HA Pols A Hofman MM Breteler 1999 Diabetes mellitus and the risk of dementia: the Rotterdam Study Neurology 53 1937 1942 1:STN:280:DC%2BD3c%2Fms1Ontg%3D%3D 10599761
118. S Oyadomari K Takeda M Takiguchi, et al. 2001 Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway Proc Natl Acad Sci USA 98 10845 10850 1:CAS:528: DC%2BD3MXntVGmsb4%3D 11526215 (Pubitemid 32878707)
119. G Palade 1975 Intracellular aspects of the process of protein synthesis Science 189 867 1:STN:280:DC%2BC3cvktVaqug%3D%3D 17812524
120. AW Pardini HT Nguyen DP Figlewicz, et al. 2006 Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis Brain Res 1112 169 178 1:CAS:528:DC%2BD28Xps1Cktro%3D 16925984 (Pubitemid 44344616)
121. CR Park RJ Seeley S Craft SC Woods 2000 Intracerebroventricular insulin enhances memory in a passive-avoidance task Physiol Behav 68 509 514 1:CAS:528:DC%2BD3cXhsFGqtbo%3D 10713291 (Pubitemid 30129236)
122. P Passa 2002 Diabetes trends in Europe Diabetes Metab Res Rev 18 Suppl 3 S3 S8 12324978
123. R Peila BL Rodriguez LJ Launer S Honolulu-Asia Aging 2002 Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study Diabetes 51 1256 1262 1:CAS:528:DC%2BD38Xis1Ois7Y%3D 11916953 (Pubitemid 34438377)
124. A Perez L Morelli JC Cresto EM Castano 2000 Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains Neurochem Res 25 247 255 1:CAS:528:DC%2BD3cXisFyiu7k%3D 10786709 (Pubitemid 30210091)
125. Periodical on Aging (1985) Department of International Economic and Social Affairs. United Nations, New York 1:1984
126. K Plaschke J Kopitz M Siegelin, et al. 2010 Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice J Alzheimers Dis 19 691 704 1:CAS:528:DC%2BC3cXht1SltL4%3D 20110613
127. JS Prichard RS Schwab WA Tillmann 1951 The effects of stress and the results of medication in different personalities with Parkinson's disease Psychosom Med 13 106 111 1:STN:280:DyaG3M%2Fmtlynuw%3D%3D 14834299
128. LP Quinn B Crook ME Hows, et al. 2008 The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B Br J Pharmacol 154 226 233 1:CAS:528:DC%2BD1cXltFOqs7k%3D 18332857 (Pubitemid 351620404)
129. Rasgon NL, Kenna HA, Wroolie TE, et al. (Dec 24, 2009) Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging (Epub ahead of print)
130. MA Reger S Craft 2006 Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin Drugs Today (Barc) 42 729 739 1:CAS:528:DC%2BD2sXht1ansbg%3D (Pubitemid 46084772)
131. MA Reger GS Watson WH Frey II, et al. 2006 Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiol Aging 27 451 458 1:CAS:528:DC%2BD28XhtlCms70%3D 15964100 (Pubitemid 43185331)
132. MA Reger GS Watson PS Green, et al. 2008 Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults J Alzheimers Dis 13 323 331 1:CAS:528: DC%2BD1cXkvV2rtrs%3D 18430999 (Pubitemid 352039034)
133. MA Reger GS Watson PS Green, et al. 2008 Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 70 440 448 1:CAS:528:DC%2BD1cXhtFels70%3D 17942819
134. O Riedel I Heuser J Klotsche R Dodel HU Wittchen GS Group 2010 Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study J Geriatr Psychiatry Neurol 23 27 34 20042544
135. Riedel O, Klotsche J, Spottke A, et al. (Feb 6, 2010b) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (Epub ahead of print)
136. ME Risner AM Saunders JF Altman, et al. 2006 Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenomics J 6 246 254 1:CAS:528:DC%2BD28Xnt1agu7k%3D 16446752 (Pubitemid 44137951)
137. E Ronnemaa B Zethelius J Sundelof, et al. 2008 Impaired insulin secretion increases the risk of Alzheimer disease Neurology 71 1065 1071 1:STN:280:DC%2BD1cnjtFKjsw%3D%3D 18401020
138. E Ronnemaa B Zethelius J Sundelof, et al. 2009 Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men Diabetologia 52 1504 1510 1:STN:280: DC%2BD1MvotVSgug%3D%3D 19455303
139. Ryan CM (2009) Cognition in children and Adolescents with type 1 diabetes. In: Biessels GJ, Luchsinger JA (eds) Diabetes and the brain. Humana Press, New York, NY, pp 251-275
140. JS Saczynski L White RL Peila BL Rodriguez LJ Launer 2007 The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study Am J Epidemiol 165 985 992 17298957 (Pubitemid 46598838)
141. M Salkovic-Petrisic S Hoyer 2007 Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach J Neural Transm Suppl 72 217 233 1:CAS:528:DC%2BD2sXhsVKns7bN 17982898
142. M Salkovic-Petrisic Z Lackovic 2003 Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes J Neural Transm 110 15 29 1:CAS:528:DC%2BD3sXltlCisg%3D%3D 12541010 (Pubitemid 36135552)
143. M Salkovic-Petrisic F Tribl M Schmidt S Hoyer P Riederer 2006 Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway J Neurochem 96 1005 1015 1:CAS:528:DC%2BD28XivFWjsr8%3D 16412093
144. R Sandyk 1993 The relationship between diabetes mellitus and Parkinson's disease Int J Neurosci 69 125 130 1:STN:280:DyaK2czmsVOmsg%3D%3D 8082998
145. R Sankar S Thamotharan D Shin KH Moley SU Devaskar 2002 Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain Brain Res Mol Brain Res 107 157 165 1:CAS:528:DC%2BD38XosFeqsL0%3D 12425944 (Pubitemid 35335533)
146. I Schweitzer V Tuckwell J O'Brien D Ames 2002 Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry 17 997 1005 12404648 (Pubitemid 35363418)
147. S Shoham C Bejar E Kovalev M Weinstock 2003 Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats Exp Neurol 184 1043 1052 1:CAS:528: DC%2BD2cXhtVSitrg%3D 14769399 (Pubitemid 38182835)
148. KC Simon H Chen M Schwarzschild A Ascherio 2007 Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease Neurology 69 1688 1695 17761552 (Pubitemid 350287125)
149. H Slodzinski LB Moran GJ Michael, et al. 2009 Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies Clin Neuropathol 28 333 343 1:STN:280:DC%2BD1Mnls1Sitw%3D%3D 19788048
150. Solfrizzi V, Scafato E, Capurso C, et al. (Dec 30 2009) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging (Epub ahead of print)
151. SF Sorrells JR Caso CD Munhoz RM Sapolsky 2009 The stressed CNS: when glucocorticoids aggravate inflammation Neuron 64 33 39 1:CAS:528: DC%2BD1MXhsFajsbnJ 19840546
152. JN Souza-Talarico EC Chaves SJ Lupien R Nitrini P Caramelli 2010 Relationship between cortisol levels and memory performance may be modulated by
153. DK Stone AD Reynolds RL Mosley HE Gendelman 2009 Innate and adaptive immunity for the pathobiology of Parkinson's disease Antioxid Redox Signal 11 2151 2166 1:CAS:528:DC%2BD1MXpvFaru7w%3D 19243239
154. X Sun DC Steffens R Au, et al. 2008 Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 65 542 550 1:CAS:528:DC%2BD1cXmsFejsLs%3D 18458206 (Pubitemid 351645050)
155. C Supnet I Bezprozvanny 2010 The dysregulation of intracellular calcium in Alzheimer disease Cell Calcium 47 2 183 189 1:CAS:528:DC%2BC3cXjtVSms7g%3D 20080301 Epub 2010 Jan 18
156. DF Swaab WC Chung FP Kruijver MA Hofman A Hestiantoro 2003 Sex differences in the hypothalamus in the different stages of human life Neurobiol Aging 24 Suppl 1 S1 S16 1:CAS:528:DC%2BD3sXkvVKiu7c%3D 12829102 discussion S17-S19
157. DF Swaab AM Bao PJ Lucassen 2005 The stress system in the human brain in depression and neurodegeneration Ageing Res Rev 4 141 194 1:CAS:528: DC%2BD2MXhtVyhsbzL 15996533 (Pubitemid 41114861)
158. M Takahashi T Yamada I Tooyama, et al. 1996 Insulin receptor mRNA in the substantia nigra in Parkinson's disease Neurosci Lett 204 201 204 1:CAS:528:DyaK28Xht1Wktbk%3D 8938265 (Pubitemid 26054674)
159. CJ Todes AJ Lees 1985 The pre-morbid personality of patients with Parkinson's disease J Neurol Neurosurg Psychiatry 48 97 100 1:STN:280: DyaL2M7lvFKmuw%3D%3D 3884742 (Pubitemid 15063902)
160. Y Tong J Shen 2009 alpha-Synuclein and LRRK2: partners in crime Neuron 64 771 773 1:CAS:528:DC%2BC3cXkvVyqurY%3D 20064381
161. M Tong A Neusner L Longato M Lawton JR Wands SM de la Monte 2009 Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease Mol Neurodegener 4 54 20034403
162. S Tyrovolas C Lionis A Zeimbekis, et al. 2009 Increased body mass and depressive symptomatology are associated with hypercholesterolemia, among elderly individuals; results from the MEDIS study Lipids Health Dis 8 10 19331683
163. JW Unger JN Livingston AM Moss 1991 Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects Prog Neurobiol 36 343 362 1:CAS:528:DyaK3MXlsFSltrk%3D 1887067
164. van den Berg E, Reijmer YD, Biessels GJ (2009) Cognition in type 2 diabetes or pre-diabetic stages. In: Biessels GJ, Luchsinger JA (eds) Diabetes and the brain. Humana Press, New York, NY, pp 295-322
165. GS Watson S Craft 2003 The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment CNS Drugs 17 27 45 1:CAS:528:DC%2BD3sXms1Sjtw%3D%3D 12467491 (Pubitemid 36044347)
166. GS Watson ER Peskind S Asthana, et al. 2003 Insulin increases CSF Abeta42 levels in normal older adults Neurology 60 1899 1903 1:CAS:528: DC%2BD3sXksVGis78%3D 12821730 (Pubitemid 36736003)
167. GS Watson BA Cholerton MA Reger, et al. 2005 Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study Am J Geriatr Psychiatry 13 950 958 16286438 (Pubitemid 46638661)
168. GS Watson T Bernhardt MA Reger, et al. 2006 Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease Neurobiol Aging 27 38 41 1:CAS:528:DC%2BD2MXht1egsr3K 16298239 (Pubitemid 41627948)
169. RA Whitmer 2007 Type 2 diabetes and risk of cognitive impairment and dementia Curr Neurol Neurosci Rep 7 373 380 1:CAS:528:DC%2BD2sXhtFaksLbP 17764626 (Pubitemid 47422778)
170. RA Whitmer DR Gustafson E Barrett-Connor MN Haan EP Gunderson K Yaffe 2008 Central obesity and increased risk of dementia more than three decades later Neurology 71 1057 1064 1:STN:280:DC%2BD1cnjtFGrsw%3D%3D 18367704
171. SC Woods RJ Seeley DG Baskin MW Schwartz 2003 Insulin and the blood-brain barrier Curr Pharm Des 9 795 800 1:CAS:528:DC%2BD3sXitFyktbs%3D 12678878 (Pubitemid 36367601)
172. M Wozniak B Rydzewski SP Baker MK Raizada 1993 The cellular and physiological actions of insulin in the central nervous system Neurochem Int 22 1 10 1:CAS:528:DyaK3sXlt1Gnug%3D%3D 8443563
173. RJ Wurtman 2005 Genes, stress, and depression Metabolism 54 16 19 1:CAS:528:DC%2BD2MXjsVers7w%3D 15877307 (Pubitemid 40546017)
174. GD Zeevalk LP Bernard C Sinha J Ehrhart WJ Nicklas 1998 Excitotoxicity and oxidative stress during inhibition of energy metabolism Dev Neurosci 20 444 453 1:CAS:528:DyaK1cXntl2ltrk%3D 9778583 (Pubitemid 28495540)
175. N Zhong G Ramaswamy KH Weisgraber 2009 Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function J Biol Chem 284 27273 27280 1:CAS:528:DC%2BD1MXhtFyjsrbE 19666463